Ketamine effects on human neuronal Na+ channels.
OBJECTIVE
Similar doses of ketamine are employed in regional and general anaesthesia. In contrast to commonly used local anaesthetic agents, accidental systemic application of local anaesthetic doses of ketamine will not result in seizure, dysrhythmia or cardiovascular depression. However, there is some doubt about the quality of regional analgesia induced by ketamine. As human sodium channels constitute an important molecular target of local anaesthetics, the study was designed to establish concentration-dependent effects of ketamine on conductance, steady-state activation and steady-state inactivation of human neuronal sodium channels. This information--that has, so far, not been published--will help to characterize further local anaesthetic properties of ketamine.


METHODS
Whole-cell patch-clamp recordings were made of sodium channels natively expressed in human neuroblastoma SH-SY5Y cells.


RESULTS
The sodium channels activated at a threshold of -60 mV and exhibited a maximal peak current at -10 mV. The voltage of half-maximal activation was -20 mV. The Na+ currents depended on the prepulse potential. The voltage of half-maximal inactivation was -80 mV. Ketamine inhibited the sodium conductance in a concentration-dependent manner (IC50 = 1140 micromol). A concentration-dependent hyperpolarizing shift of both steady-state activation and steady-state inactivation accounted for at most 5 mV.


CONCLUSIONS
The effects of ketamine on these human ion channels occur at clinical concentrations. They are consistent with the local anaesthetic action of ketamine. Whether ketamine helps to decrease the incidence of severe side-effects during regional anaesthesia needs to be addressed in further clinical studies.
Reckziegel
G
G
University of Bonn, Department of Anaesthesiology and Intensive Care Medicine, Germany.
Friederich
P
P
Urban
B W
BW
D000778:Anesthetics, Dissociative / Q000494:pharmacology*; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007649:Ketamine / Q000494:pharmacology*; D008564:Membrane Potentials / Q000187:drug effects; D009474:Neurons / Q000187:drug effects / Q000502:physiology*; D018408:Patch-Clamp Techniques; D015222:Sodium Channels / Q000187:drug effects*
D000778:Anesthetics, Dissociative; D015222:Sodium Channels; D007649:Ketamine